Hillman Laboratory

The Hillman Laboratory is a joint venture between the Gynecologic Oncology and Reproductive Medicine department and the Genomic Medicine department at The University of Texas MD Anderson Cancer Center. A major focus of the Hillman Lab is pioneering our understanding of the molecular pathogenesis of ovarian granulosa cell tumors. The lab’s work in this area is motivated by Dr. Hillman’s busy international referral practice providing medical and surgical treatment for women affected by this disease. A key long-term goal of the Hillman Lab is to discover new granulosa cell tumor therapeutic vulnerabilities and use these innovations to launch novel early-phase clinical trials focused on this rare disease.